01/20/2026
We're excited to share that Worldwide Clinical Trials has entered into a definitive agreement to acquire Catalyst Clinical Research.
By adding our expertise to Worldwide’s established leadership, we're creating a differentiated solution delivering across the therapeutic areas our customers desire most: speed, flexibility, scientific rigor, and connection with senior leadership.
Here's what this means for you:
• Deeper oncology capabilities across all indications, modalities, and phases
• A range of service models — full-service, FSP, or hybrid — tailored to your needs
• Enhanced technologies for improved study visibility, data transparency, and decision making
• Expanded global reach to support larger, more complex trials
Most importantly, we are bringing together talented teams united by a shared commitment to serve our customers with the personalized, collaborative approach both companies are known for and delivering trials with predictability, speed, and scientific rigor.
We look forward to the opportunities ahead as we work together to bring life-changing therapies to patients more quickly.
https://www.worldwide.com/newsroom/worldwide-clinical-trials-acquires-catalyst-clinical-research/?utm_source=Catalyst&utm_medium=Press-Release&crid=Variation_a&leadsource=Advertising&leadtactic=Press-Release